EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the US Patent Office (USPTO) has granted Active Biotech's US patent application 17/939,109 for laquinimod in eye disorders. "We ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...

This project offers a unique opportunity to explore circadian biology in retinal diseases and develop innovative therapeutics for DR treatment. Diabetic retinopathy (DR ... of the vascular clock in ...

This code is designed for detecting Diabetic Retinopathy in retinal fundus images using a deep learning approach. It preprocesses the images, applies data augmentation to improve model generalization, ...

Cannabis treatment could also help to protect the nerves from damage through its anti-inflammatory properties and help to prevent peripheral neuropathy. Diabetic retinopathy—damage to the eyes that ...

Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.

New Delhi: A few photographs taken from a smartphone could soon mean the difference between life and death. Healthcare workers may be able to assess the risk of oral cancer, recommend next steps and ...

(NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina experience, outlined exceptional clinical progress across its registrational program for ...

Treatment of hypertensive retinopathy begins with controlling hypertension. Some of the complications can be treated by an ophthalmologist with injectable medications into the eye as well as laser ...

ABBV-RGX-314 is being investigated as a potential one-time treatment for wet AMD, diabetic retinopathy and potentially other chronic retinal conditions. ABBV-RGX-314 consists of the NAV ® AAV8 ...